Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-04-30 Purchase | 2020-05-04 5:25 pm | FENNEC PHARMACEUTICALS Inc | FENC | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 768,000 | $6.25 | $4,800,000 | 3,993,694 (Direct) | View |
2018-03-13 Purchase | 2018-03-14 4:30 pm | REGENERX BIOPHARMACEUTICALS INC | RGRX | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 17,933,673 | $0.23 | $4,124,745 | 34,355,399 (Direct) | View |
2017-12-12 Purchase | 2017-12-14 4:15 pm | FENNEC PHARMACEUTICALS Inc | FENC | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 294,115 | $8.5 | $2,499,978 | 3,225,694 (Direct) | View |
2017-11-29 Purchase | 2017-12-01 4:25 pm | SOLIGENIX Inc | SNGX | Essetifin SPA CAVAZZA PAOLO Leadiant Biosciences Inc. Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina Former 10% Owner | 293,510 | $2.12 | $622,241 | 293,510 (Indirect Direct) | View |
2017-11-29 Sale | 2017-12-01 4:25 pm | SOLIGENIX Inc | SNGX | Essetifin SPA CAVAZZA PAOLO Leadiant Biosciences Inc. Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina Former 10% Owner | 293,510 | $2.12 | $622,241 | 293,510 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-10-15 Other | 2020-10-16 4:17 pm | 2021-04-15 2025-10-15 | REGENERX BIOPHARMACEUTICALS INC | RGRX | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 835,189 | $0 | 43,474,269 (Direct) | View |
2019-05-13 Other | 2019-05-16 4:16 pm | 2019-11-13 2024-03-01 | REGENERX BIOPHARMACEUTICALS INC | RGRX | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 3,125,000 | $0 | 42,239,080 (Direct) | View |
2019-02-26(A) Other | 2019-03-01 4:37 pm | 2019-08-26 2024-02-26 | REGENERX BIOPHARMACEUTICALS INC | RGRX | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 3,125,000 | $0 | 38,614,080 (Direct) | View |
2019-02-26 Other | 2019-02-27 5:14 pm | 2019-08-26 2024-02-26 | REGENERX BIOPHARMACEUTICALS INC | RGRX | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 2,884,615 | $0 | 38,373,695 (Direct) | View |
2018-09-27 Conversion | 2018-09-28 4:04 pm | N/A N/A | REGENERX BIOPHARMACEUTICALS INC | RGRX | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 3,133,681 | $0.06 | 34,989,080 (Direct) | View |
2018-09-27 Conversion | 2018-09-28 4:04 pm | 2013-09-12 N/A | REGENERX BIOPHARMACEUTICALS INC | RGRX | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 150,000 | $150,000 | 34,989,080 (Direct) | View |
2017-09-11(A) Ownership | 2017-10-04 09:45 am | N/A N/A | FENNEC PHARMACEUTICALS Inc | FENC | Essetifin SPA Cavazza Enrico Cavazza Silvia Cavazza Francesca Cavazza Preta Martina CAVAZZA PAOLO 10% Owner | 0 | $0 | 2,931,579 (Direct) | View |